UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Notice of Effectiveness
Effectiveness Date:	January 5, 2024 4:00 P.M.

Form:	F-3
CIK: 0001498403 Company Name: BioLineRx Ltd. File Number: 333-276323